Author: Moragas, Matias; Gomez, Sandra; Fernández, MarÃa Florencia; Golemba, Marcelo Dario; Palladino, Marcela; Borgnia, Daniela; Ruvinsky, Silvina; Fraquelli, Lidia; Buchovsky, Ana; Bologna, Rosa; Mangano, Andrea
Title: Case Report: Hyperinflammatory Status in an Immunocompromised Child With a Highly Sustained Viral Load of SARS-CoV-2 Cord-id: y24lk6t6 Document date: 2021_8_19
ID: y24lk6t6
Snippet: Coronavirus disease 2019 (COVID-19) is spreading throughout the world. Limited data are available for the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL) in immunocompromised pediatric patients. Here, we report the clinical characteristics and the dynamics of SARS-CoV-2 VL of a pediatric patient with acute myeloid leukemia who developed a hyperinflammatory status mimicked MIS-C. The clinical course was characterized by the late onset of fever, GI symptoms
Document: Coronavirus disease 2019 (COVID-19) is spreading throughout the world. Limited data are available for the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL) in immunocompromised pediatric patients. Here, we report the clinical characteristics and the dynamics of SARS-CoV-2 VL of a pediatric patient with acute myeloid leukemia who developed a hyperinflammatory status mimicked MIS-C. The clinical course was characterized by the late onset of fever, GI symptoms, rash, and respiratory distress, including oxygen requirement with sustained VL of SARS-CoV-2 around 7 log(10) RNA copies/mL for 6 weeks. It is important to note that the hyperinflammatory status developed early at the third week of hospitalization—in a context of high VL and immunocompromised status. All these characteristics make this clinical case unique. On the other hand, while many reports have characterized the dynamics of SARS-CoV-2 VL in adults and immunocompetent hosts, it remains unreported in pediatrics—even less in immunosuppressed children.
Search related documents:
Co phrase search for related documents- abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and macrophage activation: 1, 2, 3, 4
- abdominal pain and macrophage activation syndrome: 1, 2, 3, 4
- abdominal pain and maculopapular rash: 1, 2, 3, 4, 5
- abdominal pain diarrhea and acute sars severe infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- abdominal pain diarrhea and lung disease: 1
- abdominal pain diarrhea and maculopapular rash: 1, 2
- abnormal finding and lung disease: 1
- acute sars severe infection and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- acute sars severe infection and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute sars severe infection and macrophage activation syndrome: 1, 2, 3, 4, 5, 6
- acute sars severe infection and maculopapular rash: 1
- lung disease and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- lung disease and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- macrophage activation and maculopapular rash: 1
- macrophage activation syndrome and maculopapular rash: 1
Co phrase search for related documents, hyperlinks ordered by date